Literature DB >> 23458516

Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease.

Roberto Gedaly1, Paige Guidry, Daniel Davenport, Michael Daily, Jens Ronsenau, Malay Shah, Michael A Cooper, Jonathan Hundley.   

Abstract

BACKGROUND: The purpose of this study was to determine peri-operative mortality and long-term outcomes in patients undergoing liver transplantation in the US using the United Network for Organ Sharing (UNOS) database.
METHODS: This study is a retrospective review of liver transplantations (LT) recorded in the UNOS database performed between 1988 and 2010. In total, 107 411 LT were performed in the US, 357 (0.3%) were for adult polycystic liver disease (PLD). A random group of 9416 adult patients transplanted for other diagnoses was created for comparison (10% of the adult non-PLD database).
RESULTS: Two hundred and seventy-one patients in the adult PLD group were females (75.9%), the mean age was 52.3 ± 8.2 [standard deviation (SD)] years. The median length of transplantation hospital stay was 11 days (interquartile range 8-21). Patients from the PLD group versus the comparison group (9416 patients) consisted of more females, lower Model for End-Stage Liver Disease (MELD) scores (17 versus 21 points), more multi-organ transplants (41% versus 4 %), chronic renal failure (creatinine 2.7 versus 1.5) and fewer patients with chronic hepatitis C (1.4% versus 32%). Peri-operative mortality (≤30 days) was 9% in the PLD versus 6% in the comparison group; however, at 1 year PLD survival was similar (85% versus 85%) to other diagnoses and better at 3 (81% versus 77%) and 5 years (77% versus 71%, overall Log Rank P = 0.006). A similar PLD survival advantage was observed in isolated initial transplants (P = 0.019).
CONCLUSION: In spite of early technical challenges and mortality, transplantation should be considered an option for selected patients with PLD as excellent long-term outcomes can be achieved.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23458516      PMCID: PMC3608985          DOI: 10.1111/j.1477-2574.2012.00579.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  8 in total

1.  Liver transplantation for polycystic liver disease--indications and outcome.

Authors:  B I Gustafsson; S Friman; L Mjornstedt; M Olausson; L Backman
Journal:  Transplant Proc       Date:  2003-03       Impact factor: 1.066

2.  Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study.

Authors:  Loes van Keimpema; Frederik Nevens; René Adam; Robert J Porte; Panagiotis Fikatas; Thomas Becker; Preben Kirkegaard; Herold J Metselaar; Joost P H Drenth
Journal:  Transpl Int       Date:  2011-09-29       Impact factor: 3.782

3.  Extended liver resection for polycystic liver disease can challenge liver transplantation.

Authors:  Béatrice Aussilhou; Ghislaine Douflé; Catherine Hubert; Claire Francoz; Catherine Paugam; Valérie Paradis; Olivier Farges; Valérie Vilgrain; François Durand; Jacques Belghiti
Journal:  Ann Surg       Date:  2010-11       Impact factor: 12.969

4.  Model for end-stage liver disease (MELD) exception for polycystic liver disease.

Authors:  Luis Arrazola; Dilip Moonka; Robert G Gish; Gregory T Everson
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

5.  Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.

Authors:  Thomas Schnelldorfer; Vicente E Torres; Shaheen Zakaria; Charles B Rosen; David M Nagorney
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

6.  Liver transplantation for polycystic liver disease.

Authors:  J Pirenne; R Aerts; K Yoong; B Gunson; T Koshiba; I Fourneau; D Mayer; J Buckels; D Mirza; T Roskams; E Elias; F Nevens; J Fevery; P McMaster
Journal:  Liver Transpl       Date:  2001-03       Impact factor: 5.799

7.  Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.

Authors:  Gabriele I Kirchner; Kinan Rifai; Tobias Cantz; Bjoern Nashan; Christoph Terkamp; Thomas Becker; Christian Strassburg; Hannelore Barg-Hock; Siegfried Wagner; Rainer Lück; Juergen Klempnauer; Michael P Manns
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

8.  Polycystic liver disease and liver transplantation: single-institution experience.

Authors:  B Taner; D L Willingham; W R Hewitt; H P Grewal; J H Nguyen; C B Hughes
Journal:  Transplant Proc       Date:  2009-11       Impact factor: 1.066

  8 in total
  2 in total

1.  Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.

Authors:  Sahil D Doshi; Therese Bittermann; Thomas D Schiano; David Seth Goldberg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

2.  Successful Management of a Patient with Intraoperative Bleeding of More than 80,000 mL and Usefulness of QTc Monitoring for Calcium Correction.

Authors:  Yuki Sugiyama; Kazuma Aiba; Nariaki Arai; Mariko Ito; Masatoshi Urasawa; Chie Hirose; Ikuko Murakami; Ryusuke Tanaka; Tomokatsu Yamada; Keisuke Iida; Hiroyuki Nakamura; Mikito Kawamata
Journal:  Case Rep Anesthesiol       Date:  2021-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.